Rapamycin reverses insulin resistance (IR) in high-glucose medium without causing IR in normoglycemic medium

被引:60
作者
Leontieva, O. V. [1 ]
Demidenko, Z. N. [1 ]
Blagosklonny, M. V. [1 ]
机构
[1] Roswell Pk Canc Inst, Dept Cell Stress Biol, Buffalo, NY 14263 USA
关键词
insulin; Akt; mTOR; S6K; rapalogs; RIBOSOMAL S6 KINASE; MAMMALIAN TARGET; LIFE-SPAN; SKELETAL-MUSCLE; SERINE PHOSPHORYLATION; RECEPTOR SUBSTRATE-1; CELLULAR SENESCENCE; FEEDBACK LOOP; AMINO-ACID; MTOR;
D O I
10.1038/cddis.2014.178
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Mammalian target of rapamycin (mTOR) is involved in insulin resistance (IR) and diabetic retinopathy. In retinal pigment epithelial (RPE) cells, insulin activates the mTOR pathway, inducing hypoxia-inducible factor-1 alpha (HIF-1 alpha) and HIF-dependent transcription in serum-free minimum essential medium Eagle (MEM). Serendipitously, we found that insulin failed to induce the HIF-1 alpha-dependent response, when RPE cells were cultured in Dulbecco's modification of Eagle's medium (DMEM). Whereas concentration of glucose in MEM corresponds to normal glucose levels in blood (5.5 mM), its concentration in DMEM corresponds to severe diabetic hyperglycemia (25mM). Addition of glucose to MEM also caused IR. Glucose-mediated IR was characterized by basal activation of mTORC1 and its poor inducibility by insulin. Basal levels of phosphorylated S6 kinase (S6K), S6 and insulin receptor substrate 1 (IRS1) S635/639 were high, whereas their inducibilities were decreased. Insulin-induced Akt phosphorylation was decreased and restored by rapamycin and an inhibitor of S6K. IR was associated with de-phosphorylation of IRS1 at S1011, which was reversed by rapamycin. Both short (16-40 h) and chronic (2 weeks) treatment with rapamycin reversed IR. Furthermore, rapamycin did not impair Akt activation in RPE cells cultured in normoglycemic media. In contrast, Torin 1 blocked Akt activation by insulin. We conclude that by activating mTOR/S6K glucose causes feedback IR, preventable by rapamycin. Rapamycin does not cause IR in RPE cells regardless of the duration of treatment. We confirmed that rapamycin also did not impair phosphorylation of Akt at T308 and S473 in normal myoblast C2C12 cells. Our work provides insights in glucoseinduced IR and suggests therapeutic approaches to treat patients with IR and severe hyperglycemia and to prevent diabetic complications such as retinopathy. Also our results prompt to reconsider physiological relevance of numerous data and paradigms on IR given that most cell lines are cultured with grossly super-physiological levels of glucose.
引用
收藏
页码:e1214 / e1214
页数:7
相关论文
共 67 条
[1]   The Critical Role of Metabolic Pathways in Aging [J].
Barzilai, Nir ;
Huffman, Derek M. ;
Muzumdar, Radhika H. ;
Bartke, Andrzej .
DIABETES, 2012, 61 (06) :1315-1322
[2]   TOR-centric view on insulin resistance and diabetic complications: perspective for endocrinologists and gerontologists [J].
Blagosklonny, M. V. .
CELL DEATH & DISEASE, 2013, 4 :e964-e964
[3]   Once again on rapamycin-induced insulin resistance and longevity: despite of or owing to [J].
Blagosklonny, Mikhail V. .
AGING-US, 2012, 4 (05) :350-358
[4]   Rapamycin-induced glucose intolerance Hunger or starvation diabetes [J].
Blagosklonny, Mikhail V. .
CELL CYCLE, 2011, 10 (24) :4217-4224
[5]   Growth and aging: a common molecular mechanism [J].
Blagosklonny, Mikhail V. ;
Hall, Michael N. .
AGING-US, 2009, 1 (04) :357-362
[6]   Long-term Administration of Rapamycin Reduces Adiposity, but Impairs Glucose Tolerance in High-Fat Diet-fed KK/HlJ Mice [J].
Chang, Geng-Ruei ;
Wu, Ying-Ying ;
Chiu, Yi-Shin ;
Chen, Wen-Ying ;
Liao, Jiunn-Wang ;
Hsu, Hong-Ming ;
Chao, Te-Hsin ;
Hung, Siu-Wan ;
Mao, Frank Chiahung .
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2009, 105 (03) :188-198
[7]   mTOR Regulation and Therapeutic Rejuvenation of Aging Hematopoietic Stem Cells [J].
Chen, Chong ;
Liu, Yu ;
Liu, Yang ;
Zheng, Pan .
SCIENCE SIGNALING, 2009, 2 (98) :ra75
[8]   Regulation of insulin sensitivity by serine/threonine phosphorylation of insulin receptor substrate proteins IRS1 and IRS2 [J].
Copps, K. D. ;
White, M. F. .
DIABETOLOGIA, 2012, 55 (10) :2565-2582
[9]   mTOR in aging, metabolism, and cancer [J].
Cornu, Marion ;
Albert, Verena ;
Hall, Michael N. .
CURRENT OPINION IN GENETICS & DEVELOPMENT, 2013, 23 (01) :53-62
[10]   Upstream of the mammalian target of rapamycin: do all roads pass through mTOR? [J].
Corradetti, M. N. ;
Guan, K-L .
ONCOGENE, 2006, 25 (48) :6347-6360